Gut microbiota’s activation of MAIT lymphocytes could hold key to Type 1 diabetes prevention
10 Oct 2017 --- The onset of Type 1 diabetes is preceded by modification of MAIT lymphocytes, which are activated by intestinal flora, according to scientists from the Cochin Institute (CNRS/INSERM/Paris Descartes University) and their colleagues from AP-HP Necker-Enfants Malades Hospital in Paris. The MAIT lymphocyte cells – associated with mucosae and able to recognize elements of the microbiota – could, therefore, serve as new biomarkers for early detection and prevention of the illness. The researchers' findings are published in Nature Immunology. Destructive process Type 1 diabetes (T1D) is an autoimmune disease that develops when the immune system attacks beta cells in the pancreas. This destructive process is often attributed to autoreactive T lymphocytes. The innate immune system, the body's first line of defense, also plays an important role in this disease, the CNRS press release points out. MAIT cells associated with the mucosae are an integral part of this front-line immunity. They are activated by bacteria – especially those of the intestinal flora, or gut microbiota. The research team wondered what role MAIT cells played in the T1D-related disturbance of this flora and of gut mucosal homeostasis. Investigations, led by Agnès Lehuen, relied on T1D animal models studied by her team at the Cohin Institute as well as blood samples from patients under the care of Dr. Jacques Beltrand from the Necker-Enfants Malades Hospital. Findings for both the samples and the animal models showed that MAIT cells are altered before T1D develops. When T1D is diagnosed in children, the number of MAIT cells in their blood is lower than in nondiabetic children. Migration of MAIT cells to inflamed pancreatic tissue in T1D patients could explain the discrepancy. This is noted by the CNRS press release to be a very reasonable assumption since the pancreatic population of MAIT cells swells in nonobese diabetic (NOD) mice. NOD mice develop a form of diabetes very similar to the human disease. Furthermore, experiments performed by the researchers on human cells in vitro and on NOD mice suggest MAIT cells are directly linked to the destruction of pancreatic beta cells. In addition to changes in their concentration and location within the body, it appears that a functional defect in MAIT cells is linked to the modifications of the gut mucosa seen in T1D patients. Indeed, a normal function of MAIT cells is to maintain the homeostasis of this mucosa. This capacity is compromised in T1D, making the gut mucosa permeable to bacteria, which, in turn, favors an autoimmune response. Ongoing research seeks to better understand the links between MAIT cells and the gut microbiota. New strategies for prevention INSERM Transfert has filed a patent in connection with its findings, on behalf of INSERM, the CNRS and Paris Descartes University. To contact our editorial team please email us at editorial@cnsmedia.com
Related ArticlesHealth & Nutrition News Weekly Roundup: Fermentalg and DSM partner on omega 3, Curcumin gut health benefits21 Sep 2018 --- The weekly roundup is NutritionInsight's collection of global nutrition stories from the past week. Fermentalg and DSM Nutritional Products entered a five-year commercial agreement for omega 3 products. Research has found that Sabinsa's curcumin products can have a positive effect on gut health, while analysis highlighted the need for more accurate cranberry authentication tools. Mühlenchemie’s Chinese production facility has been certified to supply fortified foods to the UN World Food Programme. Health & Nutrition News High gluten diet during pregnancy could double risk of diabetes in children, study finds20 Sep 2018 --- A high gluten intake by mothers during pregnancy may be associated with an increased risk of their child developing Type 1 diabetes, a study published in The BMJ suggests. Health & Nutrition News Early life microbiome health may have lasting effect on ability to fight disease, study finds19 Sep 2018 --- The first bacteria introduced into the gut during infanthood may have a lasting impact on an individual’s long-term ability to fight chronic disease, findings from the University of Alberta have suggested. The findings could pave the way for treatments that could adjust microbiomes in infants right after birth to help ward off serious chronic diseases. Poor gut health has been linked to obesity, Type 2 diabetes, heart disease, inflammatory bowel disease, colon cancer, neurological disorders, autism and allergies. Health & Nutrition News Household cleaners can alter infant microbiota and increase obesity risk, study suggests17 Sep 2018 --- Commonly used household cleaners could be making children overweight by altering their gut microbiota, a Canadian study published in the Canadian Medical Association Journal (CMAJ) has found. Health & Nutrition News Labeling probiotics as useless is irresponsible, says IPA exec11 Sep 2018 --- Claiming that probiotics are useless is not only senseless but also irresponsible. This is according to George Paraskevakos, Executive Director of the International Probiotics Association (IPA), responding to a study that claims probiotics might not be as effective as many think. There are myriad studies underlining the efficacy of probiotics, he says, with platforms now far extending beyond the traditional area of gastrointestinal (GI) health and research moving toward treatment, rather than prevention objectives. More Articles |
